Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Zai Lab ADR | ZLAB | Sep 19, 2024 | 21.09 | -0.61 |
Zalatoris II Acquisition | ZLS | Sep 19, 2024 | 11.06 | 0.00 |
Zapata Computing | ZPTA | Sep 19, 2024 | 0.39 | +2.90 |
Zapp Electric Vehicles Group | ZAPP | Sep 19, 2024 | 3.18 | +2.58 |
ZC SP ETN REDEEM 19/07/2050 USD 25 - Ser B | AMND | Sep 19, 2024 | 47.86 | -0.64 |
ZC SP ETN REDEEM 20/10/2050 USD 25 - Series B | AMTR | Sep 19, 2024 | 66.69 | -0.29 |
Zebra Technologies A | ZBRA | Sep 19, 2024 | 363.79 | +3.40 |
Zedge B | ZDGE | Sep 19, 2024 | 3.10 | -2.21 |
ZEEKR Intelligent Technology Holding | ZK | Sep 19, 2024 | 16.45 | +8.51 |
Zentalis Pharmaceuticals | ZNTL | Sep 19, 2024 | 4.36 | +4.81 |
Zentek | ZTEK | Sep 19, 2024 | 0.75 | +1.35 |
Zenvia A | ZENV | Sep 19, 2024 | 1.50 | +2.04 |
Zeo Energy A | ZEO | Sep 19, 2024 | 2.60 | +128.07 |
Zepp Health ADR | ZEPP | Sep 19, 2024 | 3.26 | -0.31 |
Zeta Global A | ZETA | Sep 19, 2024 | 28.40 | +2.97 |
Zevia A | ZVIA | Sep 19, 2024 | 1.19 | +13.33 |
Zevra Therapeutics | ZVRA | Sep 19, 2024 | 8.02 | +2.43 |
Zhibao Technology | ZBAO | Sep 19, 2024 | 3.92 | +5.66 |
Zhihu A ADR | ZH | Sep 19, 2024 | 3.25 | 0.00 |
Zhongchao A | ZCMD | Sep 19, 2024 | 1.28 | +2.38 |
Ziff Davis | ZD | Sep 19, 2024 | 52.96 | +0.27 |
Zillow Group A | ZG | Sep 19, 2024 | 65.79 | +4.10 |
Zillow Group C Capital Stock | Z | Sep 19, 2024 | 67.84 | +4.19 |
ZIM | ZIM | Sep 19, 2024 | 20.41 | +6.75 |
Zimmer Biomet | ZBH | Sep 19, 2024 | 106.34 | +0.06 |
ZimVie | ZIMV | Sep 19, 2024 | 16.96 | +2.98 |
Zions Bank | ZION | Sep 19, 2024 | 48.45 | +3.06 |
Zions Bank A Pref | ZIONP | Sep 19, 2024 | 22.25 | +0.63 |
Zions Bank G Pref | ZIONO | Sep 19, 2024 | 26.45 | +1.19 |
ZipRecruiter A | ZIP | Sep 19, 2024 | 9.77 | -4.12 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.